The first-of-its kind gene therapy uses a patient’s skin cells to create sheets to treat the open wounds caused by the rare, ...

ANTONIO TORRES, A 24-year-old from Denver, used to spend six hours each day bathing and meticulously wrapping the red, raw ...

Zevaskyn, the first gene therapy for recessive dystrophic epidermolysis bullosa, showed significant wound healing in phase 3 ...

Epidermolysis bullosa is a rare genetic condition that makes skin so fragile that it can tear or blister at the slightest touch. Children born with it are often called “Butterfly Children” because ...

Treating our first patient is a proud moment for Abeona and a testament to the tireless resolve of our team,” said Vish ...

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of The University of Texas Medical Branch (UTMB) in ...

Epidermolysis bullosa patients, or "butterfly children," triumph through pain. Feb. 22, 2013— -- Life isn't easy for children and adults whose skin is so fragile that the tiniest friction can ...

Enabling Pivotal Phase 2/3 STEP Study in Epidermolysis BullosaPress release2025-12-09 09:28Helene Hartman, CEO of XinnateLund, Sweden – Xinnate is taking a major step toward reshaping the treatment ...

Epidermolysis Bullosa pipeline constitutes 20+ key companies continuously working towards developing 21+ Epidermolysis Bullosa treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of ...

Please provide your email address to receive an email when new articles are posted on . Krystal Biotech submitted a marketing authorization application to the European Medicines Agency for dystrophic ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye. In 1999, I defined regenerative medicine as the collection of ...

Epidermolysis bullosa is a skin condition where blisters appear following minor injuries. Epidermolysis bullosa (EB) is a group of inherited disorders in which the skin is extremely fragile. Skin ...